FDA Investigator Nancy A Bellamy

Nancy A Bellamy has conducted inspections on 134 sites in 17 countries as of 14 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
134
Last Inspection Date:
14 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
100000994
Countries of Inspections:
Argentina, United States of America, Italy, United Kingdom of Great Britain and Northern Ireland, India, South Africa, Canada, Zambia, Czechia, Belgium, Hong Kong, China, Egypt, Jordan, Chile, France, Brazil
FDA Investigators that have inspected at least one site in common with Nancy A Bellamy:
Ademola O Daramola, Alanna L Mussawwir Bias, Alice S Tsao, Allen F Hall, Amina Bashir, Andrace L Deyampert, Andrea A Branche, Anthony E Keller, RPh, Anthony R Petriella, Art O Czabaniuk, Azza Talaat, Barbara A Rusin, Barbara D Wright, Barbara Janine Breithaupt, Barbara M Frazier, Bei Y He, Bernard P Heidt, Brian J Mundo, Brian M Campbell, Brian M Marosan, Brian P Hendrickson, Brian P Putz, Bryan J Love, Byron Ho, DVM, Calvin K Cook, Camille D Brown, Carol Rivera Lopez, PhD, Caroline H Le, Catherine V Quinlan, Cathie S Marshall, CDR Kimberly Y Martin, CDR Sean T Creighton, Charisse K Green, Charles A Snipes, PhD, Charles M Spyr, Chelsea J Falkowski, Chelsea W Lamm, Cheryl A Fuhs, Constantin Y Philopoulos, Corey K Reno, Corrine M Carter, Craig A Garmendia, Crystal M Young Lewis, David A Lepay, MD, PhD, David J Gasparovich, Dawn C Olenjack, Deanna L Lampley, Denise L Burosh, Diane Cvan Leeuwen, Dina A Tallman, Douglas W Gronski, Dr. Hansong Chen, PhD, Dr. Mark J Seaton, PhD, Dr. Zhihao Qiu (Peter), PhD, Dr. Zhou Chen (nmi), MD PhD, Dylan D Yao, MD, PhD, Emily J Orban, Ephrem Hunde, PhD, Eric E Joneson, Eric S Pittman, Erma Zaimova, Felicia E Armbrustmacher, Gajendiran Mahadevan, PhD, Gary Durbiel Goldner, Gene R Gunn, George C Amedro, Gerald N Mcgirl, DDS, Hamet M Toure, PharmD MPH, Hasan A Irier, PhD, Herbert M Corbello, Jacqueline Mdiaz Albertini, James M Kewley, Jeanne J Thai, Jeffrey D Meng, Jennifer A Kemp, Jennifer C Adams, Jennifer L Sheehan, Joanne M Schlossin, Joel D Martinez, John A Kadavil, PhD, José E Meléndez, Joseph D Cooper, Joseph R Haynes, Joseph R Strelnik, Judith A Jankowski, Karen M Cooper, Katherine Szestypalow, Keith J Jasukaitis, Kelley L Clark, Kelli L Wilkinson, Kellie L Thommes, RN, Kent A Conforti, Khairy W Malek, MD, Khin Mang U, MD, Kip J Hanks, L'oreal F Walker, Larry K Austin, Laura E Garcia, Laureen F Kononen, Laureen M Geniusz, Laverne Puckett, Lawrence Y Lee, PhD, Lea Cranford, Leslie A Paul, Li Hongpaul Yeh, PhD, Linda R Kuchenthal, Linda S Jozefiak, Lisa J Joseph, Lisa J Renick, Lisa P Oakes, Lori A Gioia, Lourdes Valentin Aponte, LT Skip A Payne, LTJG Aaron B Otis, Madushini Dharmasena, PhD, Makini Cobourne Duval, PhD, Margaret Torres Vazquez, Marion W Nadeau, Mark E Parmon, Martha Sullivan Myrick, Martin K Yau, PhD, Matthew B Casale, Matthew J Gretkierewicz, Melkamu Getie Kebtie, PhD, Michael F Skelly, PhD, Michael P Anthony, Michele L Forster, PhD, Mikhail V Ovanesov, PhD, Mra Davism, Mra Mcculloughj, Mra Narulaa, Myra K Casey, Natalie A Mickelsen, DVM, Neali H Lucas, Nicholas L Paulin, Nicola M Fenty Stewart, Nilufer M Tampal, PhD, Niraj R Mehta, PhD, Paige E Shelborne, Patrick D Stone, MS, Patsy J Domingo, Paula M Laplant, Peter R Lenahan, Preston M Lee, Rasha Bamieh, Rebecca E Dombrowski, Richard W Berning, Robert D Tollefsen, Robert G Taylor, Robert Shibuya, MD, Roger F Zabinski, Rohn R Robertson, Ronda Rloyd Jones, Rosanna M Goodrich, Ruben C Ayala, PharmD, Ryan J Benedict, Saikat I Bhuiyan, Sam H Haidar, PhD, Samantha J Pinizzotto, D V M, Sargum C Sood, Seongeun Cho (Julia), PhD, Sherri J Jackson, Shirley H Isbill, Simone E Pitts, Sripal R Mada, PhD, Stephanie E Hubbard, Susan D Yuscius, Suyang Qin, Talmane J Fisher, Tawny L Colling, Thomas A Peter, Thomas J Arista, Thuy T Nguyen, LCDR, Tonnie L Carter, Tracey Asinjen Wiersma, Tracey L Harris, Tracey L Siebesma, Tracey L Taylor, Twana R Chandler, Uduak M Inokon, Vesa Vuniqi, Victoria A Murray, Wayne E Seifert, William D Tingley, William G Nelson, William R Brubaker, Xiaokuang Lai, PhD, Xikui Chen (nmi), PhD

Nancy A Bellamy's Documents

Publish Date Document Type Title
May, 2001 EIR Prof. Gianmarco Corneo, Head, Hematology Sec. - EIR, 2001-06-20
July, 2003 EIR Syneos Health Clinique Inc - EIR, 2003-07-18
March, 2003 FDA 483 UCB Pharma S.A. - Form 483, 2003-03-28
June, 2011 FDA 483 Bay Regional Medical Center IRB - Form 483, 2011-06-24
June, 2013 FDA 483 Jay H. Sandberg, D.O. - Form 483, 2013-06-04
May, 2013 EIR Cheri-Hill Kennel And Supply, Inc. - EIR, 2013-05-09
April, 2001 FDA 483 Imperial College of Medicine, Hammersmith Hospital - Form 483, 2001-04-26
August, 2012 FDA 483 Response Charles River Laboratories - Form 483R, 2012-08-15
November, 2004 EIR Parexel Bionanalytical Services Division - EIR, 2005-01-14
March, 2000 EIR Prof. Richard van Zyl-Smit - EIR, 2000-03-17
March, 2000 FDA 483 Response Prof. Richard van Zyl-Smit - Form 483R, 2000-03-17
February, 2014 EIR Zimmer, Inc. - EIR, 2014-02-07
April, 2006 EIR Yves Poulin, MD - EIR, 2006-04-07
May, 2012 EIR Northern Biomedical Research, Inc. - EIR, 2012-05-24
April, 2013 EIR St Joseph Mercy Oakland Instiutional Review Board - EIR, 2013-04-22
March, 2000 FDA 483 Tygerberg Hospital - Form 483, 2000-03-24
March, 2000 EIR Dr. M.R. Moosa - EIR, 2000-03-24
May, 2001 FDA 483 Response Prof. Gianmarco Corneo, Head, Hematology Sec. - Form 483R, 2001-05-11
February, 2014 FDA 483 Response Zimmer, Inc. - Form 483R, 2014-02-14
April, 2013 FDA 483 St Joseph Mercy Oakland Instiutional Review Board - Form 483, 2013-04-22
February, 2013 FDA 483 Ismail H. Mitha, M.D. - Form 483, 2013-02-22
April, 2007 FDA 483 Charles River Laboratories - Form 483, 2007-04-20
October, 2014 FDA 483 Charles River Laboratories - Form 483, 2014-10-10
February, 2008 EIR Burnette Foods, Inc - EIR, 2008-02-15
June, 2013 EIR Jay H. Sandberg, D.O. - EIR, 2013-06-04
March, 2003 FDA 483 Response UCB Pharma S.A. - Form 483R, 2003-04-28
June, 2010 FDA 483 Bay Regional Medical Center IRB - Form 483, 2010-06-04
April, 2001 EIR Prof. John Goldman - Dept. Of Hematology - EIR, 2001-04-26
August, 2012 EIR Charles River Laboratories - EIR, 2012-08-15
May, 2012 FDA 483 Response Northern Biomedical Research, Inc. - Form 483R, 2012-06-07
March, 2003 EIR UCB Pharma S.A. - EIR, 2003-03-28
May, 2001 FDA 483 Nuovo Ospedale San Gerardo - Univ. of Milano Bicocca - Form 483, 2001-05-03
November, 2002 EIR M. Paul Kelly, M.D., Dept. of Medicine, Univ. of Zambia - EIR, 2002-12-24
November, 2004 FDA 483 Parexel Bionanalytical Services Division - Form 483, 2004-11-19
May, 2012 FDA 483 Northern Biomedical Research, Inc. - Form 483, 2012-05-24
May, 2011 FDA 483 Michigan Center For Research Company, LLC - Form 483, 2011-05-31
July, 2003 EIR Christian Aumais, M.D. - EIR, 2003-09-17
July, 2003 FDA 483 Response Christian Aumais, M.D. - Form 483R, 2003-07-14
July, 2003 FDA 483 Christian Aumais, M.D. - Form 483, 2003-07-10
February, 2014 FDA 483 Zimmer, Inc. - Form 483, 2014-02-07
June, 2011 FDA 483 Response Bay Regional Medical Center IRB - Form 483R, 2011-06-30
June, 2010 EIR Bay Regional Medical Center IRB - EIR, 2010-06-04
April, 2007 EIR Charles River Laboratories - EIR, 2007-04-20
August, 2012 FDA 483 Charles River Laboratories - Form 483, 2012-08-15
May, 2011 FDA 483 Michigan Center For Research Company, LLC - Form 483, 2011-05-24
April, 2001 FDA 483 Response Prof. John Goldman - Dept. Of Hematology - Form 483R, 2001-04-26
June, 2011 EIR Bay Regional Medical Center IRB - EIR, 2011-06-24
October, 2014 EIR Charles River Laboratories - EIR, 2014-10-10

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more